A story by ABC News reports on the U.S. Food and Drug Administration’s changes to prescribing information for the diabetes drug Byetta, in response to reports about kidney problems.
According to the story, the FDA received 78 reports of kidney function problems from patients taking Byetta between April 2005 and October 2008, most of which occurred in patients with pre-existing kidney disease or one or more risk factors for developing kidney problems.
Studies have also linked Byetta, as well as the diabetes ...
continue reading...